In our patients, higher expression of Bcl-2 was found in SCLC compared to EPNEC (46.3% versus 28.3%, respectively; p = 0.03) which is consistent with the data shown by Brenner B et al [7]. Here, BCL2 is linked to small cell lung carcinoma.